ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 33.38M | 28.34M | 21.10M | 13.98M | 10.64M |
| Gross Profit | -33.38M | -28.34M | -21.10M | -13.98M | -10.64M |
| SG&A Expenses | 6.79M | 7.06M | 6.98M | 6.63M | 6.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.17M | 35.40M | 28.08M | 20.61M | 16.83M |
| Operating Income | -40.17M | -35.40M | -28.08M | -20.61M | -16.83M |
| Income Before Tax | -39.72M | -29.28M | -8.43M | -934.00K | 2.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.72 | -29.28 | -8.43 | -0.93 | 2.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.72M | -29.28M | -8.43M | -934.00K | 2.78M |
| EBIT | -40.17M | -35.40M | -28.08M | -20.61M | -16.83M |
| EBITDA | -- | -6.00M | -10.43M | -13.14M | -16.81M |
| EPS Basic | -22.60 | -18.63 | -4.98 | -1.04 | -0.42 |
| Normalized Basic EPS | -14.12 | -10.07 | -1.54 | 0.92 | 1.31 |
| EPS Diluted | -22.72 | -18.74 | -5.02 | -1.08 | -0.46 |
| Normalized Diluted EPS | -14.12 | -10.07 | -1.55 | 0.92 | 1.30 |
| Average Basic Shares Outstanding | 7.32M | 6.13M | 5.38M | 4.78M | 4.17M |
| Average Diluted Shares Outstanding | 7.32M | 6.13M | 5.38M | 4.78M | 4.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |